The Future Of Rebates: MedPAC Will Be Watching For Pricing Law Impacts

The US Medicare Payment Advisory Commission is finally able to analyze the impact of rebates on actual prescription drug spending – but immediate recommendations may not be viable given the changes coming from implementation of the Inflation Reduction Act.